Improve cough strength using SpiroGym
- Trial ID
- NCT06481540
- Official Title
- Effect of the SpiroGym App on Voluntary Cough Strength in Parkinson's Disease
- Goal
- Improve cough strength using SpiroGym
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- General University Hospital, Prague
- Study Type
- INTERVENTIONAL
- Enrollment
- 60 participants
- Conditions
- Parkinson Disease, Voluntary Peak Cough Strength, mHealth
- Interventions
- Expiratory muscle strength training + SpiroGym application, Expiratory muscle strength training
Summary For Families
Aiming to boost voluntary cough strength so people with Parkinson's can clear their airways better and lower the risk of choking or chest infections. The program uses expiratory muscle strength training, which exercises the muscles that drive a strong cough by breathing out against resistance, and the SpiroGym app guides, times, and tracks those training sessions to keep practice consistent. It is a non‑drug, at-home approach that is intended to be used alongside your usual Parkinson's medications, which should be on a stable dose. Looking for adults 40 to 80 years old with Parkinson's on stable dopaminergic therapy; people with other neurological diseases, significant cognitive impairment (MoCA <19), breathing disorders, recent smoking, or uncontrolled high blood pressure are excluded.
Locations
- General University Hospital, Prague, Czechia
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Expiratory muscle strength training + SpiroGym application. Aiming to boost voluntary cough strength so people with Parkinson's can clear their airways better and lower the risk of choking or chest infections. The program uses expiratory muscle strength training, which exercises the muscles that drive a strong cough by breathing out against resistance, and the SpiroGym app guides, times, and tracks those training sessions to keep practice consistent. It is a non‑drug, at-home approach that is intended to be used alongside your usual Parkinson's medications, which should be on a stable dose. Looking for adults 40 to 80 years old with Parkinson's on stable dopaminergic therapy; people with other neurological diseases, significant cognitive impairment (MoCA <19), breathing disorders, recent smoking, or uncontrolled high blood pressure are excluded.
- Who can participate?
- Participants must be between 40 Years and 80 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 1 year and 4 months.
- Will I get the real drug or a placebo?
- It depends on the trial design. Some Parkinson's trials are placebo controlled, meaning a portion of participants get an inactive comparison while others get the experimental treatment. Some use crossover designs so everyone eventually receives the active treatment at some point. Observational trials do not use a placebo at all because they are not testing a new treatment. The consent form for any specific trial spells out the design and your odds of being assigned to placebo before you enroll.
- How often will I need to visit the study site?
- Visit frequency varies by trial. Many Parkinson's studies require an in person visit every 4 to 12 weeks during the active treatment phase, with shorter or longer gaps depending on the design. The site coordinator can give you the full visit schedule before you sign anything, so you know what the time commitment looks like.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Will travel or parking be reimbursed?
- Many trials reimburse for parking, mileage, and sometimes lodging if the site is far from your home. Reimbursement policies vary by sponsor and site. When you contact the trial team, ask specifically what is covered and how reimbursement is processed.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.